Position in EDIT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,015,641
-$376,126 QoQ
Shares Held
411,192
-39.4% QoQ
Ownership
0.420%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 80.23696959084808.ToString("F0")%
Shared 0.ToString("F0")%
None 19.76303040915193.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. EDIT ranks #254 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in EDIT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,015,641 | 411,192 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,391,767 | 678,913 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $3,775,033 | 1,087,907 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,125,499 | 1,420,683 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,084,345 | 2,658,921 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,956,587 | 1,540,623 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $4,457,530 | 1,307,195 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $4,288,148 | 918,234 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $13,235,286 | 1,783,732 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $12,809,736 | 1,264,535 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $10,410,633 | 1,334,697 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $14,031,799 | 1,704,958 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,354,165 | 876,437 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,834,954 | 883,310 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $11,086,204 | 905,736 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,663,452 | 1,070,453 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $21,336,060 | 1,121,770 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $25,665,827 | 966,698 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $37,508,009 | 913,048 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $45,847,753 | 809,459 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $40,584,474 | 966,297 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $58,503,496 | 834,453 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $30,223,957 | 1,077,119 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $29,310,524 | 990,890 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $15,146,588 | 763,822 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||